Oct 10 |
Trending tickers: Tata Investment Corporation, Tesla, HSBC, GSK and BMW
|
Oct 10 |
FTSE 100 Live 10 October: GSK shares rise on $2.2bn Zantac settlement, property firm gets £1.1bn bid
|
Oct 10 |
GSK shares jump after landmark £1.68bn heartburn drug settlement
|
Oct 10 |
GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
|
Oct 10 |
GSK shares jump on $2.2 billion Zantac settlement
|
Oct 9 |
Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday
|
Oct 9 |
GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits
|
Oct 9 |
GSK stock rallies 8% on Zantac litigation settlement (update)
|
Oct 9 |
GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement Deal, Stock Surges
|
Oct 9 |
GSK, Pfizer seeing drop in demand for RSV vaccines: report
|